Fresh From the Bench: Latest Federal Circuit Court Cases
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
PersonalWeb Techs., LLC v. Apple, Inc., Appeal No. 2018-1599 (Fed. Cir. March 8, 2019)
In a second appeal in this inter partes review matter, the Federal Circuit reversed the PTAB’s finding of invalidity, ending this five-year old case.
The patent in this case concerns certain improvements in data processing systems. In 2015, the PTAB found the challenged claims unpatentable over two prior art references. On February 14, 2017, the Federal Circuit affirmed the PTAB’s claim construction, but remanded the obviousness findings. PersonalWeb Techs., LLC v. Apple, Inc., 848 f. 3d 987 (Fed. Cir. 2017). In that case, the primary dispute was about a single claim element. The Board had cited only “Stefik” as satisfying that element, but Apple had “made clear in its petition that it relied on only Woodhill for this element.” The Court disagreed with the Board’s reliance on Stefik and instructed the Board to evaluate whether the limited portion of Woodhill taught the element. The Court also reversed the Board’s analysis concerning the purported motivation to combine the art, finding it insufficient.
Read more.
Written by: Scott D. Eads and Nika Aldrich, Schwabe Williamson & Wyatt
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…